Trapidil is a vasodilator and antiplatelet agent used therapeutically to manage ischemic coronary heart disease, as well as conditions involving liver cirrhosis and renal insufficiency. By inhibiting platelet… Read more
Trapidil is a vasodilator and antiplatelet agent used therapeutically to manage ischemic coronary heart disease, as well as conditions involving liver cirrhosis and renal insufficiency. By inhibiting platelet aggregation and enhancing microcirculation, this pharmaceutical compound plays a critical role in clinical care. To support the rigorous analytical requirements of pharmaceutical development, this category provides high-quality reference standards, including the active pharmaceutical ingredient, identified degradation products, and related impurities. These compounds are essential for laboratories conducting impurity profiling and method validation, ensuring accurate quantification and characterization during quality control processes. Additionally, researchers rely on stable isotope labelled compounds to serve as internal standards in mass spectrometry-based assays, allowing for precise monitoring of drug substance stability and integrity throughout the analytical lifecycle.